Stock listing
NASDAQ:GTHX G1 Therapeutics Inc Stock
Follow G1 Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:GTHX
$7.15 USD
Close on Sep 17, 2024 · No longer trades
- Lowest – highest close
- $1.12 – $67.97 USDSince May 17, 2017 · lowest Oct 9, 2023 · highest Sep 13, 2018
Delisted NASDAQ:GTHX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GTHX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
G1 Therapeutics Inc on 6ix
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 1, 2024
- Decks
- 9 decks · latest Jan 8, 2024
Events
| Call | When | Status |
|---|---|---|
| G1 Therapeutics (GTHX) Q1 2024 Earnings Call | Wed, May 01, 2024 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2023 Earnings Call | Wed, Feb 28, 2024 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q3 2023 Earnings Call | Wed, Nov 01, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2023 Earnings Call | Wed, Aug 02, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2023 Earnings Call | Wed, May 03, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2022 Earnings Call | Wed, Mar 01, 2023 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q3 2022 Earnings Call | Wed, Nov 02, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2022 Earnings Call | Wed, Aug 03, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2022 Earnings Call | Wed, May 04, 2022 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2021 Earnings Call | Wed, Feb 23, 2022 · 8:30 AM ET | Replay |
All 14 calls
| Call | When | Status |
|---|---|---|
| G1 Therapeutics (GTHX) Q3 2021 Earnings Call | Wed, Nov 03, 2021 · 8:30 AM ET | Replay |
| G1 Therapeutics (GTHX) Q2 2021 Earnings Call | Wed, Aug 04, 2021 · 4:30 PM ET | Replay |
| G1 Therapeutics (GTHX) Q1 2021 Earnings Call | Wed, May 05, 2021 · 4:30 PM ET | Replay |
| G1 Therapeutics (GTHX) Q4 2020 Earnings Call | Wed, Feb 24, 2021 · 4:30 PM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 42nd Annual J.P. Morgan Healthcare Conference (January 2024) | Conference | 31 slides | Jan 8, 2024 |
| 41st Annual J.P. Morgan Healthcare Conference (January 2023) | Conference | 37 slides | Jan 9, 2023 |
| 40th Annual J.P. Morgan Healthcare Conference 2022 | Conference | 32 slides | Jan 10, 2022 |
| Investor Presentation (February 2021) | Investor deck | 38 slides | Feb 16, 2021 |
| 39th Annual J.P. Morgan Healthcare Conference 2021 | Conference | 34 slides | Jan 11, 2021 |
| 38th Annual J.P. Morgan Healthcare Conference (January 2020) | Conference | 31 slides | Jan 13, 2020 |
| Investor Day (October 2019) | Investor day | 58 slides | Oct 1, 2019 |
| Investor Presentation (November 2017) | Investor deck | 42 slides | Nov 13, 2017 |
| Wedbush PacGrow Healthcare Conference 2017 | Conference | 41 slides | Aug 17, 2017 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Fredric N Eshelman Other companies: Aravive Inc (Executive Chairman, Director · Apr 8, 2020 – Oct 24, 2022 · Past); Jasper Therapeutics, Inc. (Director · Nov 19, 2019 – Nov 19, 2019 · Past); Hyperion DeFi, Inc. (Director · Jan 24, 2018 – Nov 17, 2021 · Past); Bausch Health Companies Inc. (Director · Mar 8, 2016 – Apr 30, 2018 · Past); The Medicines Company (Executive Chairman, Director · Aug 28, 2015 – May 31, 2018 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Pharmaceutical Product Development Inc (Executive Chairman, Director · Feb 22, 2006 – Dec 5, 2011 · Past) | Director · May 16, 2017 – Jun 11, 2020 · Past |
| Garry A Nicholson Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Mar 25, 2020 – Jun 22, 2023 · Past); Turning Point Therapeutics Inc (Director · Jan 22, 2020 – Aug 17, 2022 · Past); Five Prime Therapeutics Inc (Director · May 10, 2017 – Apr 16, 2021 · Past); Tesaro Inc (Director · May 14, 2015 – Jan 22, 2019 · Past) | Director · Sep 12, 2018 – Sep 18, 2024 · Past |
| Alicia Secor Other companies: Zevra Therapeutics, Inc. (Director, Audit Committee, Compensation Committee · Since at least Dec 2, 2025); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); GW Pharmaceuticals plc (Director · Oct 1, 2018 – May 5, 2021 · Past); Juniper Pharmaceuticals Inc (President and CEO, Director · Aug 1, 2016 – Aug 14, 2018 · Past); Larimar Therapeutics, Inc. (Chief Commercial Officer · Mar 31, 2016 – Mar 31, 2016 · Past) | Director · Jun 17, 2021 – Sep 18, 2024 · Past |
| Glenn P. Muir Other companies: Cytek Biosciences, Inc. (Director · Since at least Jun 10, 2026); Neuronetics, Inc. (Board Member · Since at least Jun 27, 2018); Repligen Corporation (Director · Since at least Sep 14, 2015); Lifeward Ltd. (Director · Dec 31, 2015 – Jun 27, 2017 · Past); Hologic Inc (Executive VP and CFO · Feb 1, 2006 – May 8, 2014 · Past) | Director · May 16, 2017 – Sep 18, 2024 · Past |
| Seth Rudnick Other companies: Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 11, 2017 · Past); Square 1 Financial Inc (Director · Mar 24, 2014 – Oct 6, 2015 · Past); POZEN Inc (Director · Jul 25, 2011 – Jun 23, 2015 · Past); Immunicon Corp (Director · Jan 19, 2006 – Jan 19, 2006 · Past) | Director · May 16, 2017 – Jun 29, 2021 · Past |
| Willie A Deese Other companies: Public Service Enterprise Group Incorporated (Director · Since at least Feb 16, 2016); Dentsply Sirona Inc. (Director · Since at least Feb 11, 2011); CDK Global Holdings LLC (Director · Sep 29, 2014 – Jul 6, 2022 · Past); Merck & Company, Inc. (Exe V-P & Pres. MMD · Nov 3, 2009 – Feb 22, 2016 · Past) | Director · Jun 7, 2018 – Jun 23, 2022 · Past |
| Barclay A Phillips Other companies: Immunic, Inc. (Director · Since at least Nov 18, 2019); Novavax, Inc. (SVP, Chief Financial Officer · Jun 24, 2013 – Jul 31, 2017 · Past); Acorda Therapeutics Inc (Director · Feb 9, 2006 – Jun 13, 2008 · Past) | SVP & Chief Financial Officer · Nov 13, 2017 – Jan 2, 2019 · Past |
| Tyrell J. Rivers Other companies: ADC Therapeutics SA (Non-Executive Director · Since at least Jan 2, 2024); Viela Bio Inc (Director · Oct 2, 2019 – Mar 15, 2021 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – Oct 17, 2018 · Past) | Director · May 16, 2017 – May 16, 2017 · Past |
| Christy L Shaffer Other companies: CalciMedica, Inc. (Director · Sep 24, 2020 – Mar 23, 2023 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 20, 2024 · Past) | Director · May 16, 2017 – Nov 30, 2017 · Past |
| Cynthia L. Flowers Other companies: Lisata Therapeutics, Inc. (Director · Since at least Nov 7, 2018); Kadmon Holdings Inc (Director · Jan 22, 2019 – Nov 8, 2021 · Past) | Director · Jun 7, 2018 – Sep 18, 2024 · Past |
All 27 people
| Person | Seat |
|---|---|
| Andrew Witty Other companies: UnitedHealth Group Incorporated (CEO, UHG, Director · Aug 4, 2017 – Mar 18, 2025 · Past) | Director · Jul 11, 2017 – Jun 12, 2019 · Past |
| Jacks Lee Other companies: Vaxcyte, Inc. (Director · Since at least Nov 27, 2023) | Director · Jun 27, 2022 – Sep 18, 2024 · Past |
| James S Hanson Other companies: Fortrea Holdings Inc. (General Counsel · Since at least Jun 9, 2023) | General Counsel · Jun 25, 2018 – Jan 3, 2023 · Past |
| Jennifer K Moses Other companies: Viridian Therapeutics, Inc. (Director · Since at least Jul 14, 2021) | CFO · Jan 2, 2018 – Jan 3, 2023 · Past |
| John Demaree Other companies: Karyopharm Therapeutics Inc. (Chief Commercial Officer · Mar 16, 2020 – Feb 25, 2021 · Past) | Chief Commercial Officer · Jul 3, 2018 – Feb 6, 2020 · Past |
| Mark A. Velleca Other companies: Black Diamond Therapeutics, Inc. (Chief Executive Officer · Since at least Aug 9, 2021) | Director · May 16, 2017 – Aug 8, 2023 · Past |
| Rajesh Malik Other companies: POINT Biopharma Global Inc (Director · Jun 30, 2021 – Dec 26, 2023 · Past) | Chief Medical Officer · May 16, 2017 – Sep 18, 2024 · Past |
| Andrew Perry | Chief Commercial Officer · Aug 16, 2021 – Sep 18, 2024 · Past |
| Gregory J Mossinghoff | Chief Business Officer · May 16, 2017 – May 16, 2017 · Past |
| Jay Strum | Chief Scientific Officer · May 16, 2017 – Jan 2, 2019 · Past |
| John E Bailey Jr | President and CEO, Director · Mar 12, 2020 – Sep 18, 2024 · Past |
| John W V Umstead | Chief Financial Officer · Mar 15, 2023 – Sep 18, 2024 · Past |
| Mark Avagliano | Chief Business Officer · Jul 29, 2019 – Sep 18, 2024 · Past |
| Monica R Thomas | Chief Legal & People Officer · May 22, 2023 – Sep 18, 2024 · Past |
| Norman Sharpless | Director · Jul 22, 2022 – Sep 18, 2024 · Past |
| Soma Gupta | Chief Commercial Officer · Mar 31, 2020 – Jan 4, 2021 · Past |
| Terry L Murdock | Chief Operating Officer · Aug 1, 2017 – Sep 18, 2024 · Past |
Log in to ask 6ix AI your own questions about G1 Therapeutics Inc.